BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 25264103)

  • 1. EED regulates epithelial-mesenchymal transition of cancer cells induced by TGF-β.
    Oktyabri D; Tange S; Terashima M; Ishimura A; Suzuki T
    Biochem Biophys Res Commun; 2014 Oct; 453(1):124-30. PubMed ID: 25264103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
    Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
    PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines.
    Terashima M; Tange S; Ishimura A; Suzuki T
    J Biol Chem; 2017 Jan; 292(1):82-99. PubMed ID: 27852821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.
    Enkhbaatar Z; Terashima M; Oktyabri D; Tange S; Ishimura A; Yano S; Suzuki T
    Cell Cycle; 2013 Jul; 12(13):2100-12. PubMed ID: 23759590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM2B is involved in the epigenetic regulation of TGF-β-induced epithelial-mesenchymal transition in lung and pancreatic cancer cell lines.
    Wanna-Udom S; Terashima M; Suphakhong K; Ishimura A; Takino T; Suzuki T
    J Biol Chem; 2021; 296():100213. PubMed ID: 33779563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of epithelial-mesenchymal transition by KDM6A histone demethylase in lung cancer cells.
    Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1407-1413. PubMed ID: 28698146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 is involved in silencing of WNT5A during epithelial-mesenchymal transition of colon cancer cell line.
    Tao J; Shi L; Huang L; Shi H; Chen H; Wang Y; Wang T
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2211-2219. PubMed ID: 28748258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
    Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
    Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EZH2 inhibition promotes epithelial-to-mesenchymal transition in ovarian cancer cells.
    Cardenas H; Zhao J; Vieth E; Nephew KP; Matei D
    Oncotarget; 2016 Dec; 7(51):84453-84467. PubMed ID: 27563817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.
    Zhao S; Zhang Y; Zheng X; Tu X; Li H; Chen J; Zang Y; Zhang J
    J Cell Physiol; 2015 Nov; 230(11):2706-17. PubMed ID: 25808945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
    Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
    Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
    Tryndyak VP; Beland FA; Pogribny IP
    Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
    Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
    Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
    J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
    Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
    Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIX1 promotes epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation.
    Ono H; Imoto I; Kozaki K; Tsuda H; Matsui T; Kurasawa Y; Muramatsu T; Sugihara K; Inazawa J
    Oncogene; 2012 Nov; 31(47):4923-34. PubMed ID: 22286765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.